 |
Molika Ashford is a GenomeWeb contributing editor and covers personalized medicine and molecular diagnostics. E-mail Molika Ashford. |
MD Anderson RPPA Study Reveals New Potential Drug Targets in Small Cell Lung Cancer
September 14, 2012
MD Anderson RPPA Study Reveals New Potential Drug Targets in Small Cell Lung Cancer
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Data from Side-Out Breast Cancer Study Suggests Potential of Proteomics for Personalizing Therapy
June 7, 2013 / ProteoMonitor - TCGA Breast Cancer Study Demonstrates Benefits of Integrating Genomic, Proteomic Data
September 28, 2012 / ProteoMonitor - Theranostics Health to Launch Breast Cancer Dx in Early 2013, Raise $5M to $10M in Funding
June 15, 2012 / ProteoMonitor - Phosphoproteomics Study Drives Phase I Trial Testing Pfizer ALK Inhibitor as Breast Cancer Therapy
November 18, 2011 / ProteoMonitor - GMU Team Builds Phosphoproteomic-based Pathway Activation Profiles of NCI-60 Cancer Cell Lines
May 17, 2013 / ProteoMonitor